{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:24:20Z","timestamp":1761823460366},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.lpm.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T04:55:08Z","timestamp":1328590508000},"page":"406-413","source":"Crossref","is-referenced-by-count":4,"title":["Ost\u00e9oporose cortisonique"],"prefix":"10.1016","volume":"41","author":[{"given":"Serge","family":"Perrot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lpm.2012.01.003_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1756-185X.2009.01415.x","article-title":"Glucocorticoid-induced osteoporosis: unawareness or negligence in India?","volume":"12","author":"Gera","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"10.1016\/j.lpm.2012.01.003_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","article-title":"Prevalence of long-term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice","volume":"61","author":"Gudbjornsson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.lpm.2012.01.003_bib0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/RHU.0b013e31819b65bd","article-title":"Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice","volume":"15","author":"Ledwich","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.lpm.2012.01.003_bib0020","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/ard.2007.072157","article-title":"EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases","volume":"66","author":"Hoes","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2012.01.003_bib0025","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010\u00a0Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.lpm.2012.01.003_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","article-title":"The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis","volume":"79","author":"Van Staa","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.lpm.2012.01.003_bib0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00198-003-1548-3","article-title":"Oral glucocorticoid use is associated with an increased risk of fracture","volume":"15","author":"Steinbuch","year":"2004","journal-title":"Osteoporosis Int"},{"key":"10.1016\/j.lpm.2012.01.003_bib0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bone.2006.02.005","article-title":"High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving glucocrticoid therapy: a cross-sectional outpatient study","volume":"39","author":"Angeli","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.lpm.2012.01.003_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.lpm.2012.01.003_bib0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/ard.45.10.852","article-title":"Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids","volume":"45","author":"Verstraeten","year":"1986","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.lpm.2012.01.003_bib0055","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/40.12.1375","article-title":"Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis","volume":"40","author":"de Nijs","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2012.01.003_bib0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","article-title":"A simple score for estimating the long-term risk of fractures in patients using oral glucocorticoids","volume":"98","author":"Van Staa","year":"2005","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.lpm.2012.01.003_bib0065","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","article-title":"Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis","volume":"54","author":"Van Staa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.lpm.2012.01.003_bib0235","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-011-1584-3","article-title":"Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids","volume":"23","author":"Ghazi","year":"2012","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.lpm.2012.01.003_bib0075","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.lpm.2012.01.003_bib0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","article-title":"Low-dose prednisone induces rapid reverisal axial bone loss in patients with rheumatoid arthritis. A randomized controlled study","volume":"119","author":"Laan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2012.01.003_bib0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","article-title":"Effects of inhaled gluococorticoids on bone density in premenopausal women","volume":"345","author":"Israel","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2012.01.003_bib0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/157488608785699487","article-title":"Skeletal effects of systemic and topical corticosteroids","volume":"3","author":"Vestergaard","year":"2008","journal-title":"Curr Drug Saf"},{"issue":"10","key":"10.1016\/j.lpm.2012.01.003_bib0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00198-004-1606-5","article-title":"Are inhaled corticosteroids associated with an increased risk of fracture in children?","volume":"15","author":"van Staa","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lpm.2012.01.003_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9343(02)01297-4","article-title":"The risk of osteoporosis in Caucasian men and women with obstructive airways disease","volume":"114","author":"Sin","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.lpm.2012.01.003_bib0105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/thx.46.11.803","article-title":"Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study","volume":"46","author":"Luengo","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.lpm.2012.01.003_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of gluococorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.01.003_bib0115","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss; a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parralel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.lpm.2012.01.003_bib0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jocd.2011.05.014","volume":"14","author":"Leib","year":"2011","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.lpm.2012.01.003_bib0125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2005-0646","article-title":"Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression","volume":"90","author":"Russcher","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2012.01.003_bib0130","first-page":"31","article-title":"11\u00a0beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlison","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lpm.2012.01.003_bib0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.lpm.2012.01.003_bib0140","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bone.2003.11.026","article-title":"Perspectives on glucocorticoid-induced osteoporosis","volume":"34","author":"Canalis","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.lpm.2012.01.003_bib0145","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/en.140.10.4382","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.lpm.2012.01.003_bib0150","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrendo.2010.190","article-title":"The multiple faces of autoimmune-mediated bone loss","volume":"6","author":"Schett","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lpm.2012.01.003_bib0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","article-title":"Bone loss in inflammatory disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J Endocrinol"},{"issue":"3","key":"10.1016\/j.lpm.2012.01.003_bib0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/ard.2007.076604","article-title":"Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis","volume":"67","author":"Chopin","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2012.01.003_bib0165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.lpm.2012.01.003_bib0170","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.12.035","article-title":"BMP\/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis","volume":"379","author":"Hayashi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.lpm.2012.01.003_bib0175","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jc.2002-012101","article-title":"The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence","volume":"87","author":"Rubin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.lpm.2012.01.003_bib0180","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/jc.2004-0164","article-title":"Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis","volume":"89","author":"Dovio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2012.01.003_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.1780390215","article-title":"The systemic efect of intraarticular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis","volume":"39","author":"Emkey","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2012.01.003_bib0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.55.2.143","article-title":"Changes in bone mass during low dose corticosteroid treatment in patients with polymyalgia rheumatica: a double-blind prospective comparison between prednisolone and deflazacort","volume":"55","author":"Krogsgaard","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2012.01.003_bib0195","first-page":"995","article-title":"Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3-year follow-up","volume":"23","author":"Adachi","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2012.01.003_bib0200","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrock","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2012.01.003_bib0205","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO;2-E","article-title":"The role of vitamin D in corticosteroid-induced osteoporosis. A meta-analytic approach","volume":"42","author":"Amin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2012.01.003_bib0210","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"HORIZON investigators. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2012.01.003_bib0215","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bone.2009.12.032","article-title":"Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate","volume":"46","author":"Burshell","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.lpm.2012.01.003_bib0220","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3949\/ccjm.77a.10003","article-title":"How to prevent glucocorticoid-induced osteoporosis","volume":"77","author":"Dore","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.lpm.2012.01.003_bib0225","series-title":"Glucocorticoidinduced osteoporosis. Guidelines for prevention and treatment","author":"Compston","year":"2002"},{"key":"10.1016\/j.lpm.2012.01.003_bib0230","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00198-009-1114-8","article-title":"Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis","volume":"21","author":"Beukelman","year":"2010","journal-title":"Osteoporos Int"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498212000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T07:55:22Z","timestamp":1543218922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498212000127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0755498212000127"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2012.01.003","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}